Development of erosive gastrointestinal lesions during risperidone treatment in two patients with Williams syndrome.
Valeria
V
Savoja
Stefano
S
Vicari
D004941:Esophagitis / Q000139:chemically induced*; D006801:Humans; D008297:Male; D010437:Peptic Ulcer / Q000139:chemically induced*; D018967:Risperidone / Q000009:adverse effects*; D018980:Williams Syndrome / Q000188:drug therapy*; D055815:Young Adult
D018967:Risperidone